[Close]  
Pharmaceutical market research logo; 24-years of Excellence in Market Research since 1988 roundel.

United Kingdom    France   Germany   Saudi Arabia   Spain

>

Pharmacogenomics for Clinical Use and in Drug Development

Pharmacogenomics for Clinical Use and in Drug Development

Table of Contents

Market Study
Published: June 2009
Pages: 244
Tables: 74
From: GBP 2125.00  Buy Now!
Research from: TriMark Publications
Sector: Drug Delivery

Pharmacogenomics, the science of individualizing drug therapy based on the genetic makeup of individual patients, offers an unusual opportunity for future market growth. Applying pharmacogenomics would allow doctors to treat specific segments of the population based on their particular responses to a drug.

The knowledge of the likely effectiveness of a drug in a patient makes the drug more reliable, and fewer drugs would have to be taken off the market due to adverse reactions in some, but not all, of the patients to whom they were administered. Additionally, reducing the occurrence of adverse effects to a drug effectually reduces the cost of patient care overall. This TriMark Publications study examines the market for diagnostic tests based on this science and the clinical measurement methods, the reagents and supplies being utilized in clinical medicine and the pharmaceutical industry.

This report presents an overview of the latest information regarding emerging new products and industry trends and will not only quantify, but also, qualify the pharmacogenomic market segments as an area of research, product development and investment opportunity. Forecasts of the pharmacogenomic market and an analysis of products in the worldwide diagnostics market will provide a basis for understanding the significance of past developments and the immense possibilities of the future.

Top of Page